Harbin Medisan Pharmaceutical Co.,Ltd.’s Net Profit Dropped 92.4% in 2022

Harbin Medisan Pharmaceutical Co.,Ltd. (哈尔滨三联药业股份有限公司) (002900.SZ) reported a net profit of 26.5 million yuan in 2022, down 92.4% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, up 8.7% year-on-year.

At the end of the reporting period, it had 3.3 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 37.4%.